Search Ontology:
ChEBI
afamelanotide
- Term ID
- CHEBI:136034
- Synonyms
-
- 4-Nle-7-Phe-alpha-MSH
- [Nle(4),D-Phe(7)]-alpha-MSH
- Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
- afamelanotida
- afamelanotide
- afamelanotidum
- CUV 1647
- CUV-1647
- CUV1647
- melanotan I
- melanotan-1
- N-acetyl-L-seryl-L-tyrosyl-L-seryl-L-norleucyl-L-alpha-glutamyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valinamide
- N-acteyl-L-Ser-L-Tyr-L-Ser-L-Nle-L-Glu-L-His-D-Phe-L-Arg-L-Trp-Gly-L-Lys-L-Pro-L-Val-NH2
- NDP-alpha-MSH
- NDP-MSH
- Nle(4)-D-Phe(7)-alpha-melanocyte-stimulating hormone
- Scenesse
- Definition
- A polypeptide comprising of 13 amino acids which is an analogue of alpha-melanocyte stimulating hormone. It is approved as a dermatologic drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria.
- References
-
- CAS:75921-69-6
- DrugBank:DB04931
- Drug_Central:4836
- KEGG:D10511
- PMID:16293341
- PMID:16647700
- PMID:19144952
- PMID:21073357
- PMID:21597671
- PMID:23277150
- PMID:23407924
- PMID:23884489
- PMID:25230094
- PMID:25402764
- PMID:25470471
- PMID:25494545
- PMID:25607635
- PMID:25607828
- PMID:26132941
- PMID:26979527
- PMID:28003770
- PMID:28063031
- PMID:30517779
- PMID:31660977
- PMID:31987791
- PMID:32186677
- PMID:32459219
- PMID:32811524
- Patent:NZ554427
- Wikipedia:Afamelanotide
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from afamelanotide
Phenotype where environments contain afamelanotide
Phenotype modified by environments containing afamelanotide
Phenotype affecting afamelanotide
Human Disease Model